Publications

Oct 1, 2011

Inhibition of dengue virus infections in cell cultures and in AG129 mice by a small interfering RNA targeting a high conserved sequence

Stein DA, Perty ST, Buck MD, Oehmen CS, Fischer MA, Poore E, Smith JL, Lancaster AM, Hirsch AJ, Slifka MK, Nelson JA, Shresta S, Fruh K
Jul 1, 2011

Better late than never: antivirals for dengue

Perry ST, Buck MD, Shresta S
Feb 1, 2011

Important advances in the field of anti-dengue virus research

Julander JG, Perry ST, Shresta S
Feb 1, 2011

STAT2 mediates innate immunity to Dengue virus in the absence of STAT1 via the type I interferon receptor

Perry ST, Buck MD, Lada SM, Schindler C, Shresta S
Yauch LE, Prestwood TR, May MM, Morar MM, Zellweger RM, Peters B, Sette A, Shresta S
Feb 27, 2025

A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity.

Ana-Sosa-Batiz F, Verma SK, Shafee N, Miller R, Conner C, Hastie KM, Timis J, Maule E, Nguyen MN, Tran L, Varghese K, Madany H, Street AE, Zandonatti M, Moi ML, Jarnagin K, Webb DR, Saphire EO, Kim K, Shresta S.
Dec 1, 2024

Genomic surveillance of SARS-CoV-2 in Nepal

Khadka B, Napit R, Mihindukulasuriya KA, Shrestha S, Rauniyar R, Tuladhar ET, Droit L, Paredes AM, Jha R, Raut R, Jha BK, Handley SA, Elong-Ngono A, Shresta S, Wang D, Manandhar KD.
Apr 3, 2025

Enhanced durability of a zika virus self-amplifying rna vaccine through combinatorial ox40 and 4-1bb agonism

Lu HH, Dos Santos Alves RP, Li QH, Eder L, Timis J, Madany H, Chuensirikulchai K, Varghese KV, Singh A, Tran LL, Street A, Elong Ngono A, Croft M, Shresta S
Dec 19, 2024

Co-immunization with spike and nucleocapsid based DNA vaccines for long-term protective immunity against SARS-CoV-2 Omicron

Pinto PBA, Timis J, Chuensirikulchai K, Li QH, Lu HH, Maule E, Nguyen M, Alves RPDS, Verma SK, Ana-Sosa-Batiz F, Valentine K, Landeras-Bueno S, Kim K, Hastie K, Saphire EO, Alves A, Elong Ngono A, Shresta S.
Nov 13, 2025

Genomic sequencing and neutralizing serological profiles during acute dengue infection: A 2017 cohort study in Nepal

Prajapati S, Elong Ngono A, Mc Cauley M, Timis J, Shrestha S, Bastola A, Mandal SK, Ray Yadav S, Napit R, Moi ML, Yamabhai M, M Sessions O, Shresta S, Manandhar KD.
Mar 25, 2025

Zika but not Dengue virus infection limits NF-κB activity in human monocyte-derived dendritic cells and suppresses their ability to activate T cells

Wang YT, Branche E, Xie J, McMillan RE, Ana-Sosa-Batiz F, Lu HH, Li QH, Clark AE, Valls Cuevas JM, Viramontes KM, Garretson AF, Dos Santos Alves RP, Heinz S, Benner C, Carlin AF, Shresta S